Literature DB >> 27911126

Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands.

M K van der Kooij1, A Joosse1, F M Speetjens1, G A P Hospers2, C Bisschop2, J W B de Groot3, R Koornstra4, C U Blank5, E Kapiteijn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27911126     DOI： 10.1080/0284186X.2016.1260773

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  13 in total

1.  Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma.

Authors:  Yanyan Tang; Yi He; Lei Shi; Liting Yang; Jinpeng Wang; Yu Lian; Chunmei Fan; Ping Zhang; Can Guo; Shanshan Zhang; Zhaojian Gong; Xiayu Li; Fang Xiong; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng
Journal:  Oncotarget       Date:  2017-06-13

Review 2.  Focus on cutaneous and uveal melanoma specificities.

Authors:  Charlotte Pandiani; Guillaume E Béranger; Justine Leclerc; Robert Ballotti; Corine Bertolotto
Journal:  Genes Dev       Date:  2017-04-15       Impact factor: 11.361

Review 3.  Clinicopathological and prognostic significance and molecular mechanisms governing uveal melanoma.

Authors:  Meng-Yu Wu; Tzu-Ting Lai; Wan-Ting Liao; Chia-Jung Li
Journal:  Ther Adv Med Oncol       Date:  2020-06-08       Impact factor: 8.168

Review 4.  Targeted Therapy and Immunotherapy for Melanoma in Japan.

Authors:  Kenjiro Namikawa; Naoya Yamazaki
Journal:  Curr Treat Options Oncol       Date:  2019-01-24

5.  Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study.

Authors:  Markus V Heppt; Teresa Amaral; Katharina C Kähler; Lucie Heinzerling; Jessica C Hassel; Markus Meissner; Nicole Kreuzberg; Carmen Loquai; Lydia Reinhardt; Jochen Utikal; Evelyn Dabrowski; Anja Gesierich; Claudia Pföhler; Patrick Terheyden; Kai-Martin Thoms; Lisa Zimmer; Thomas K Eigentler; Michael C Kirchberger; Henner M Stege; Friedegund Meier; Max Schlaak; Carola Berking
Journal:  J Immunother Cancer       Date:  2019-11-13       Impact factor: 13.751

Review 6.  The Role of Immune Checkpoint Blockade in Uveal Melanoma.

Authors:  Anja Wessely; Theresa Steeb; Michael Erdmann; Lucie Heinzerling; Julio Vera; Max Schlaak; Carola Berking; Markus Vincent Heppt
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

7.  Comprehensive analysis of cutaneous and uveal melanoma liver metastases.

Authors:  Esmee P Hoefsmit; Elisa A Rozeman; Trieu My Van; Petros Dimitriadis; Oscar Krijgsman; Jordan W Conway; Ines Pires da Silva; Jacqueline E van der Wal; Steven L C Ketelaars; Kaspar Bresser; Annegien Broeks; Ron M Kerkhoven; Jason W Reeves; Sarah Warren; Pia Kvistborg; Richard A Scolyer; Ellen W Kapiteijn; Daniel S Peeper; Georgina V Long; Ton N M Schumacher; Christian U Blank
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

Review 8.  Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment.

Authors:  Lionel Larribère; Jochen Utikal
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

9.  Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma.

Authors:  Kalijn Fredrike Bol; Eva Ellebaek; Lise Hoejberg; Mette Marie Bagger; Mathilde Skaarup Larsen; Tobias Wirenfeldt Klausen; Ulrich Heide Køhler; Henrik Schmidt; Lars Bastholt; Jens Folke Kiilgaard; Marco Donia; Inge Marie Svane
Journal:  Cancers (Basel)       Date:  2019-10-03       Impact factor: 6.639

10.  Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal Melanoma.

Authors:  Qianxing Mo; Lixin Wan; Michael J Schell; Heather Jim; Shelley S Tworoger; Guang Peng
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.